![Adding abiraterone to standard hormone therapy improves survival in advanced prostate cancer](https://www.hoaapharmacy.com/wp-content/uploads/2017/06/IMG_5212.jpeg)
Previously, treatment for new metastatic prostate cancer had been to treat with hormone therapy (androgen deprivation therapy to deplete testosterone levels) with possibly adding chemotherapy for higher risk patients. A recent study called the LATITUDE study showed that patients who received androgen deprivation therapy along with a drug called abitaterone acetate (a pill that further… Read more »